FDA sets up committee over emergency vaccine use, bypassing White House
New requirements will add to the time to review any vaccine, potentially past election day, but the FDA won’t bend to political pressure
New York — The US Food and Drug Administration (FDA) plans to have an expert panel review any Covid-19 vaccine application for emergency use, and wants to see at least two months of safety data, according to a document posted by the agency on Tuesday.
The requirements will almost certainly add to the time it will take to review any vaccine, potentially past President Donald Trump’s goal of having one by election day next month. While the FDA has said it plans to work as quickly as possible, it has also said it won’t cut scientific corners or bend to political pressure to rush a vaccine...